Altea Therapeutics Corp — Form D
Altea Therapeutics Corp of Atlanta, GA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-13. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-05-13
- Form: D
- Accession: 0001310392-09-000005
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $3.0M
- Date of first sale: 2009-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-71591
Issuer
- Name: Altea Therapeutics Corp
- CIK: 0001310392
- Entity type: Corporation
- Jurisdiction: DE
- Address: 387 Technology Circle NW, Suite 100, Atlanta, GA, 30313
- Phone: (404) 835-6310
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| ANTHONY B EVNIN | Director | CAMBRIDGE, MA |
| William R Good | Director | Cranbury, NJ |
| Paul E Tierney | Director | Atlanta, GA |
| Jesse I Treu | Director | Princeton, NJ |
| Steven P Damon | Executive Officer | Atlanta, GA |
| Michael Hatch | Executive Officer | Tampa, FL |
| Harold Shlevin | Executive Officer | Marietta, GA |
| Frank E Tagliaferri | Executive Officer | Atlanta, GA |
| Angela Walsh | Executive Officer | Atlanta, GA |
| Steven Damon | Executive Officer | Atlanta, GA |
| Anthony Evnin | Director | Cambridge, MA |
| Jesse Treu | Director | Duluth, GA |
| Alan Smith | Executive Officer | Rydal, PA |
| Ruth Devenyns | Director | THOUSAND OAKS, CA |
| Eric Tomlinson | Director | Altanta, GA |
| Eric Tomlinson | Executive Officer | Altanta, GA |
| Frank Tagliaferri | Executive Officer | Atlanta, GA |
| William Good | Director | Salt Lake City, UT |
| Paul Tierney | Director | New York, NY |
| Angela Walsh | Director | Atlanta, GA |
| Deborah Eppstein | Director | Salt Lake City, UT |
Other filings by this issuer (1)
More